Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers.
about
Darifenacin: a muscarinic M3-selective receptor antagonist for the treatment of overactive bladder.Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction.A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderContribution of the M3 muscarinic receptors to the vasodilator response to acetylcholine in the human forearm vascular bed.Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin.Rationale for the use of anticholinergic agents in overactive bladder with regard to central nervous system and cardiovascular system side effects.Darifenacin for the treatment of overactive bladder.Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients.Systematic review and meta-analysis: do clinical trials testing antimuscarinic agents for overactive bladder adequately measure central nervous system adverse events?Anticholinergics for overactive bladder therapy: central nervous system effects.Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder.Cardiovascular effects of antimuscarinic agents in overactive bladder.Treatment of Overactive Bladder in the Elderly Female: The Case for Trospium, Oxybutynin, Fesoterodine and Darifenacin.World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction.Current and future pharmacotherapy for treating overactive bladder.Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg.Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder.Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder.Differential Prescribing of Antimuscarinic Agents in Older Adults with Cognitive Impairment.Evaluation of cognitive function in healthy older subjects treated with fesoterodine.
P2860
Q34575850-1911707D-0E23-4B94-9F10-974794CCF143Q35183599-E6A17A75-95AE-47EC-B99C-75E7AFF043BBQ35183619-1E5258C4-C462-4148-9E24-55EA02708DC8Q35546189-10F87609-BBEC-49C8-9162-F5271B1BB161Q36803404-BFE78292-DE67-486E-8892-FDF0C6E08502Q37242704-DFBAF3B7-9AF9-41CF-BC78-EB319B6AB73FQ37399563-7AE098BF-B75E-40B0-A9E3-66427C5BBAFCQ37608354-31B63AC1-4FBD-45B5-B176-0A54A871E678Q37879017-4E304FB4-73C7-4738-BC9E-03475C6FB0B6Q37896119-FE08B2BE-D563-4986-9170-782689EC9E9FQ37954372-4C3168D0-94A4-46E8-A03F-7DA286B85E7AQ37990531-2CB4272A-5394-4A23-8A17-4CF9EFBF9AA8Q38116972-840B834D-7B3A-4448-979F-859FA45BDD7EQ38590670-0D92FB5F-3958-42B8-B8E8-FEF71521889DQ38646237-53EAD346-E129-4B54-9551-BBBBE358C016Q38851523-F1352182-27F0-46E9-B048-432301FC548DQ43277955-D5949BCE-5EA8-4599-827F-84A0D683A437Q48054495-F111DF28-6874-4D37-AE7A-914AEEF520AFQ48160047-44F47BF4-1CF1-4825-B826-862D1D5702B9Q50533611-3FC80D4C-FD0B-48CC-89D8-40892C98F4C7Q50753347-8B36734F-3F94-41A5-BBCA-FC327567A2AD
P2860
Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pharmacodynamic effects of dar ...... ladder, in healthy volunteers.
@ast
Pharmacodynamic effects of dar ...... ladder, in healthy volunteers.
@en
Pharmacodynamic effects of dar ...... ladder, in healthy volunteers.
@nl
type
label
Pharmacodynamic effects of dar ...... ladder, in healthy volunteers.
@ast
Pharmacodynamic effects of dar ...... ladder, in healthy volunteers.
@en
Pharmacodynamic effects of dar ...... ladder, in healthy volunteers.
@nl
prefLabel
Pharmacodynamic effects of dar ...... ladder, in healthy volunteers.
@ast
Pharmacodynamic effects of dar ...... ladder, in healthy volunteers.
@en
Pharmacodynamic effects of dar ...... ladder, in healthy volunteers.
@nl
P2860
P1433
P1476
Pharmacodynamic effects of dar ...... ladder, in healthy volunteers.
@en
P2093
Gary G Kay
Keith A Wesnes
P2860
P304
P356
10.1111/J.1464-410X.2005.05745.X
P577
2005-11-01T00:00:00Z